The European Medicines Agency backed the use of Novo Nordisk’s (NYSE: NVO) popular drug Wegovy to help ease heart failure
1 year ago
Smaller rivals to UnitedHealth’s tech unit Change Healthcare say they are signing longer-term contracts with hospitals and other customers who
NEW YORK – On Wednesday, Hims & Hers Health (NYSE: HIMS), the U.S. telehealth company, said it will sell compounded
On Wednesday, GSK (NYSE: GSK), the British drugmaker, said it had agreed to settle two lawsuits in California that claimed
Novo Nordisk (NYSE: NVO), the Danish drugmaker, expects its diabetes drug Ozempic will “very likely” be on the U.S. government’s
On Tuesday, U.S. Senator Bernie Sanders said he received confirmation from major generic pharmaceutical companies that they could sell copycat
Walgreens Boots Alliance (NASDAQ: WBA) agreed to pay $106.8 million to settle charges it fraudulently billed the U.S. government for
Eli Lilly (NYSE: LLY) is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely
On Thursday, GSK (NYSE: GSK), the British drugmaker, announced positive results from a mid-stage trial of its seasonal influenza vaccine
The market for weight-loss treatments is expected to see 16 new drugs vying for a slice of the lucrative business
On Tuesday, Baltimore said that it has settled with Walgreens (NASDAQ: WBA) over claims that the pharmacy operator fueled opioid
BRUSSELS – Teva (NYSE: TEVA), the world’s largest generic drugmaker, will be hit with an EU antitrust fine in the
